NIH is hopeful the research will enable doctors to detect signs of stroke damage earlier, opening the door for them to initiate treatments in a timelier manner.

Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers. 

The Class 2 recall pertains to the system's built-in shielding and collimation accessories. 

Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%. 

The system was built with patients in mind, and its compact design has the potential to expand access to the modality where it may have previously been lacking. 

There’s no shortage of technically impressive AI applications for primary care. Yet these tools tend to lag well behind AI models aimed at clinical specialties when it comes to integration into routine practice.

Negotiated professional prices for hospital-based radiology services are about 43% higher than independents vs. 16% more for PE-backed rad groups.

Four nursing homes operated by ProMedica Health System are alleged to have failed to adequately feed patients, treat wounds and keep patients clean. The DOJ said the facilities falsified records to cover their tracks.

GLP-1 drugs have been taking the United States by storm in recent years. According to a new study of more than 90,000 patients, some of these medications can also make a big impact on reducing adverse heart failure outcomes.